Reduction of 123I-iomazenil uptake in haemodynamically and metabolically impaired brain areas in patients with cerebrovascular disease.

MLA

Hayashida, K., et al. “Reduction of 123I-Iomazenil Uptake in Haemodynamically and Metabolically Impaired Brain Areas in Patients with Cerebrovascular Disease.” Nuclear Medicine Communications, vol. 17, no. 8, Aug. 1996, pp. 701–05. EBSCOhost, https://doi.org/10.1097/00006231-199608000-00010.

APA

Hayashida, K., Hirose, Y., Tanaka, Y., Miyashita, K., Ishida, Y., Miyake, Y., & Nishimura, T. (1996). Reduction of 123I-iomazenil uptake in haemodynamically and metabolically impaired brain areas in patients with cerebrovascular disease. Nuclear Medicine Communications, 17(8), 701–705. https://doi.org/10.1097/00006231-199608000-00010

Chicago

Hayashida, K., Y. Hirose, Y. Tanaka, K. Miyashita, Y. Ishida, Y. Miyake, and T. Nishimura. 1996. “Reduction of 123I-Iomazenil Uptake in Haemodynamically and Metabolically Impaired Brain Areas in Patients with Cerebrovascular Disease.” Nuclear Medicine Communications 17 (8): 701–5. doi:10.1097/00006231-199608000-00010.